EAHP European Statements Survey 2018, focusing on Section 1: Introductory Statements and Governance, Section 3: Production and Compounding, and Section 4: Clinical Pharmacy Services
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
34930791
PubMed Central
PMC8717797
DOI
10.1136/ejhpharm-2019-002028
PII: ejhpharm-2019-002028
Knihovny.cz E-zdroje
- Klíčová slova
- EAHP statements of hospital pharmacy, clinical pharmacy, health services administration & management, pharmacy management (personnel), survey,
- MeSH
- farmaceuti MeSH
- farmacie * MeSH
- lékárny * MeSH
- lidé MeSH
- nemocniční lékárny * MeSH
- průzkumy a dotazníky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: The 2018 EAHP European Statements Survey focused on sections 1, 3 and 4 of the European Statements of Hospital Pharmacy. Statistical data on the level of implementation and on the main barriers to implementation of the Statements were collected. A further aim was to identify barriers in general, such as lack of awareness. METHODS: An online questionnaire was sent to all hospital pharmacies in EAHP member countries. Data were analysed at Keele University School of Pharmacy, UK. As with previous reports, the survey was divided into three sections: section A, asking general questions about the hospital pharmacy; Section B, addressing questions about the current activity of pharmacists around each statement from Sections 1, 3 and 4; and Section C, focusing on their ability to implement the statements. RESULTS: 719 complete responses were obtained from a sample of 5164 hospital pharmacies, giving a response rate of 14% (719/5164). Section A results indicated that 45% (323/719) of responders worked in teaching hospitals, 79% (568/719) of hospital pharmacies had 10 or fewer pharmacists, and 48% (345/719) of hospital pharmacies served over 500 beds. Section B results found a high percentage of positive responses for activity in section 1 (introductory statements and governance) and section 3 (production and compounding). However, responses to questions in section 4 (clinical pharmacy services) were more variable, with 6 of the 15 questions being answered positively by less than half of respondents. The five questions that revealed the lowest implementation levels were then analysed in greater detail. These questions corresponded to Statements 4.4, 4.5, 4.8, 1.1, and 4.2, which need the greatest effort for implementation. The major identified barriers to implementation were 'lack of capacity' and that 'other health professionals in the hospital fulfil the tasks'. CONCLUSIONS: This survey provides useful information on the implementation status (and the barriers to, and drivers of implementation) of sections 1, 3 and 4 of the Statements. This will allow the EAHP to plan its implementation support programme for its members. To increase the quality of data, as well as the feedback to hospital pharmacies, the EAHP is planning to combine the survey with the self-assessment tool of the European Statements of Hospital Pharmacy.
Centre for Medicines Optimisation Keele University Keele Staffs UK
Hospital Pharmacy Institute for orthopaedic surgery Banjica Beograd Serbia
Hospital Pharmacy Motol University Hospital Praha Praha Czech Republic
hospitalar 5 N de Gaia Portugal
Keele University Centre for Medicines Optimisation Keele University Keele Staffordshire UK
Krankenhausapotheke Stadtisches Klinikum Munchen GmbH Munchen Germany
Zobrazit více v PubMed
Anon . The European statements of hospital pharmacy. Eur J Hosp Pharm 2014;21:256–8. 10.1136/ejhpharm-2014-000526 DOI
Maskrey N, Underhill J. The European statements of hospital pharmacy: achieving consensus using Delphi and world Café methodologies. Eur J Hosp Pharm 2014;21:264–6. 10.1136/ejhpharm-2014-000520 DOI
Horák P, Peppard J, Sýkora J, et al. . EAHP survey and European statements of hospital pharmacy – can we achieve a perfect match? Eur J Hosp Pharm 2014;21:291–3. 10.1136/ejhpharm-2014-000541 DOI
EAHP . European statements of hospital pharmacy survey results 2018, statements sections 1, 3 and 4. Available: http://www.eahp.eu/sites/default/files/eahp_survey_report_2018-19.pdf
Horák P, Peppard J, Sýkora J, et al. . EAHP European statements baseline survey 2015: results. Eur J Hosp Pharm 2016;23:69–75. 10.1136/ejhpharm-2016-000889 PubMed DOI PMC
SurveyMonkey . SurveyMonkey and GDPR. Available: https://www.surveymonkey.com
Quintens C, De Rijdt T, Van Nieuwenhuyse T, et al. . Development and implementation of "Check of Medication Appropriateness" (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance. BMC Med Inform Decis Mak 2019;19:29. 10.1186/s12911-019-0748-5 PubMed DOI PMC
Phan H, Williams M, McElroy K, et al. . Implementation of a student pharmacist-driven medication history service for ambulatory oncology patients in a large academic medical center. J Oncol Pharm Pract 2019;25:1419–24. 10.1177/1078155219831066 PubMed DOI
EAHP . Hospital self-assessment tool. Available: http://sat.eahp.eu/en/home
Frontini R. Falsified medicines directive: are we heading in the right direction? 2017. Available: 10.5301/maapoc.0000011 DOI